Richard Rees

Richard Rees is a declared insider of Creo Medical Group plc, with filings sourced from RNS (LSE). We count 5 filings; the first trade dates from 26 May 2022 and the latest from 24 October 2024.

Market trades split into 3 purchases (€80k) and 2 sales. No amount is published for 4 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 2 purchases and 2 sales.

On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 24 October 2024: an open-market sale, in Creo Medical Group plc. The latest purchase dates back some time: it was published 745 days ago, on 24 October 2024. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.